share_log

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

為什麼鮑達斯生物股票的交易價格較高 60%?以下是其他股票在星期二的中午交易中移動
Benzinga Real-time News ·  2023/01/24 13:12
Gainers
贏家
Baudax Bio, Inc. (NASDAQ:BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery. bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 46% to $2.34 after the company announed the publication of results of its clinical trial in peer-reviewed journal Respiratory Research. Axcella Health Inc. (NASDAQ:AXLA) shares jumped 36% to $0.59 after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue. Grom Social Enterprises, Inc. (NASDAQ:GROM) gained 34.9% to $2.9950. Inhibikase Therapeutics, Inc. (NASDAQ:IKT) jumped 22.4% to $0.9190. Ontrak, Inc. (NASDAQ:OTRK) gained...
博達克斯生物公司納斯達克(BXRX:BXX)股價飆升59.7%,至5.03美元,此前該公司宣佈了BX1000第二階段試驗的第一個中期分析結果,該試驗針對接受擇期手術的患者使用神經肌肉阻滯。 生物親...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論